Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/GSD stock hub

TSXV/GSD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSXV/GSDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
31M
TSX Venture Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSXV/GSD
In the news

Latest news · TSXV/GSD

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-83.4
P25 -121.5P50 -40.9P75 0.5
ROIC-87.1
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSXV/GSD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
CAD
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
11
Employees Change
3%
Employees Change Percent
37.5
Enterprise value
CAD 29.9M
Exchange
TSX Venture Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA2518341078
Last refreshed
2026-05-10
Market cap
CAD 31M
Price
CAD 11.15
Price currency
CAD
Rev Per Employee
1,018,199.2x
Sector
Healthcare
Sic
2834
Symbol
tsxv/GSD
Website
https://groupedevonian.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-28.95%
EV Earnings
-3.33x
EV/FCF
-3.08x
EV/Sales
2.93x
FCF yield
-31.26%
P/B ratio
3.93x
P/S ratio
3.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-42.08%
EBITDA Margin
-40.11%
Gross margin
44.52%
Gross Profit
CAD 4.5M
Gross Profit Growth
-57.25%
Gross Profit Growth Q
-98.73%
Gross Profit Growth3 Y
76.06%
Net Income
CAD -9M
Pretax Margin
-88.28%
Profit Margin
-88.16%
Profit Per Employee
CAD -897,645
ROA
-14.02
Roa5y
-7.23
ROCE
-53.7
ROE
-83.36
Roe5y
-32.8
ROIC
-87.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
3.24%
Cagr3y
-4.74%
Cagr5y
-7.2%
Revenue Growth
-66.65x
Revenue Growth Q
-94.47x
Revenue Growth3 Y
66.54x
Revenue Growth5 Y
45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CAD 0.53
Assets
CAD 9.6M
Cash
CAD 1.3M
Current Assets
CAD 2.5M
Current Liabilities
CAD 1.6M
Debt
CAD 158,479
Debt Equity
CAD 0.02
Debt FCF
CAD -0.02
Equity
CAD 7.9M
Interest Coverage
-107.4
Liabilities
CAD 1.7M
Long Term Assets
CAD 7.1M
Long Term Liabilities
CAD 79,001
Net Cash
CAD 1.1M
Net Cash By Market Cap
CAD 3.66
Net Cash Growth
-86.3%
Net Debt Equity
CAD -0.14
Tangible Book Value
CAD 3M
Tangible Book Value Per Share
CAD 1.08
WACC
12.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.56
Inventory Turnover
95.05
Net Working Capital
CAD -327,006
Quick ratio
1.31
Working Capital
CAD 885,853
Working Capital Turnover
CAD 8.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-6.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
3.24%
200-day SMA
10.7
3Y total return
-13.57%
50-day SMA
11.91
50-day SMA vs 200-day SMA
50over200
5Y total return
-31.17%
All Time High
57
All Time High Change
-80.44%
All Time High Date
2017-05-19
All Time Low
4.5
All Time Low Change
147.78%
All Time Low Date
2024-10-29
ATR
0.93
Beta
1.49
Beta1y
0.76
Beta2y
1.56
Ch YTD
-2.19
High
11.15
High52
15
High52 Date
2025-11-24
High52ch
-25.67%
Low
11.15
Low52
5.1
Low52 Date
2025-09-19
Low52ch
118.63%
Ma50ch
-6.37%
Price vs 200-day SMA
4.19%
RSI
47.1
RSI Monthly
48.34
RSI Weekly
48.91
Sharpe ratio
1.18x
Sortino ratio
2.04
Total Return
-6.08%
Tr YTD
-2.19
Tr1m
-7.08%
Tr1w
11.5%
Tr3m
11.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -4.3M
Operating margin
-42.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
2,430,034%
Net Borrowing
-59,825
Shares Insiders
0.65%
Shares Out
2,780,866
Shares Qo Q
0.08%
Shares Yo Y
6.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
CAD -10.3M
Average Volume
799.45x
Bv Per Share
2.86
CAPEX
CAD -6,500
Ch1m
-7.08
Ch1w
11.5
Ch1y
3.24
Ch3m
11.5
Ch3y
-13.57
Ch5y
-31.17
Ch6m
23.89
Change
11.5%
Change From Open
0
Close
10
Days Gap
11.5
Depreciation Amortization
200,186
Earnings Date
2026-06-25
EBIT
CAD -4.3M
EBITDA
CAD -4.1M
EPS
CAD -3.43
F Score
2
FCF
CAD -9.7M
FCF EV Yield
-32.45x
FCF Per Share
CAD -3.49
Financing CF
2,561,706
Fiscal Year End
July
Income Tax
CAD -12,684
Investing CF
-6,500
Is Primary Listing
1
Last Earnings Date
2025-11-28
Last Report Date
2026-01-31
Last Split Date
2026-01-22
Last Split Type
Reverse
Ma150
10.94
Ma150ch
1.89%
Ma20
12.24
Ma20ch
-8.92%
Net CF
-7,131,418
Next Earnings Date
2026-06-25
Open
11.15
Ppne
2,191,108
Price Date
2026-05-08
Ptbv Ratio
10.34
Relative Volume
0.15x
Revenue
10,181,992x
SBC By Revenue
6.07x
Share Based Comp
617,821
Tax By Revenue
-0.12x
Tr6m
23.89%
Volume
0
Z Score
4.41
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSXV/GSD pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/GSD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+3.2%
S&P 500 1Y: n/a
3Y total return
-13.6%
S&P 500 3Y: n/a
5Y total return
-31.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TSXV/GSD?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+0.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+6.1%
Negative means the company is buying back shares.
Technical

TSXV/GSD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.1
Neutral momentum band
Price vs 200-day MA
+4.2%
50/200-day relationship not available
Beta (5Y)
1.49
More volatile than the market
Sharpe ratio
1.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSXV/GSD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/GSD stock rating?

tsxv/GSD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/GSD analysis?

The full report lives at /stocks/tsxv/GSD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/GSD?

The latest report frames tsxv/GSD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/GSD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.